Benign tumors
Superficial Angiomyxoma
Definition
- •
An uncommon distinct type of myxoma characterized by the presence of thin-walled blood vessels
- •
This is likely to represent the same entity as cutaneous myxoma, including the lesions seen in Carney complex
Clinical features
Epidemiology
- •
Presents during adulthood and shows slight male predilection
- •
Commonly affects the head and neck and trunk areas
Presentation
- •
Usually solitary
- •
Size: 1 to 5 cm
Prognosis and treatment
- •
Benign tumors, but frequently recur locally
- •
No reports of metastasis
Pathology
Histology
- •
Dermal or subcutaneous lobules of plump, stellate or spindle-shaped, bland-looking cells embedded in basophilic, highly vascular, myxoid matrix
- •
Aggregates of inflammatory cells, particularly neutrophils, are commom
- •
May contain entrapped epithelial component that resembles keratinous cysts
- •
Some consider this equivalent to cutaneous myoma
Immunohistochemistry/special stains
- •
Neoplastic cells express vimentin and sometimes CD68, factor XIIIa, and CD34
- •
The myxoid stroma can be highlighted with Alcian blue or mucicarmine stains
Main differential diagnoses
- •
Aggressive angiomyxoma
- •
Angiomyofibroblastoma
- •
Low-grade myxofibrosarcoma
- •
Nerve sheath myxoma
Intramuscular Myxoma
Definition
- •
Benign mesenchymal tumor composed of bland, spindle-shaped cells embedded in a characteristically hypovascular myxoid stroma
Clinical features
Epidemiology
- •
An exclusively intramuscular neoplasm
- •
It usually involves the large skeletal muscles of extremities, particularly the thigh
- •
Superficial cases involving head and neck and hypothenar area of the hand are extremely rare
- •
Majority of patients are adults
- •
Two-thirds of patients are females
- •
Rare cases are associated with Mazabraud syndrome (single or multiple intramuscular myxomas and polyostotic fibrous dysplasia)
Presentation
- •
Most cases present as slowly growing, painless muscular masses
- •
Angiographic studies demonstrate poorly vascularized neoplasms
Prognosis and treatment
- •
Surgical excision is virtually always curative
- •
Recurrence is unusual even after incomplete resection
- •
Cellular variant has a higher tendency for recurrence
Pathology
Histology
- •
Classically described as “hypocellular” and “hypovascular” tumor
- •
Commonly infiltrates adjacent muscle fibers
- •
Abundant myxoid stroma with sparse, capillary-sized blood vessels
- •
Uniform, cytologically bland, spindle-shaped cells with eosinophilic cytoplasm
- •
A cellular variant has been described
- •
Tumors typically lack cytological atypia, mitoses, and necrosis
Immunhistochemistry/special stains
- •
Neoplastic cells express vimentin
- •
Variable expression with CD34, desmin, and smooth muscle actin
- •
S100 protein is not normally expressed
Genetic profile
- •
Recurrent point mutations involving the GNAS1 gene are common
Main differential diagnoses
- •
Chondrosarcoma
- •
Low-grade myxofibrosarcoma
- •
Low-grade fibromyxoid sarcoma
- •
Myxoid liposarcoma
- •
Myxoid neurothekoma
Juxtaarticular Myxoma
Definition
- •
A rare, benign mesenchymal tumor that histologically resembles intramuscular myxoma and usually arises in the vicinity of a joint
Clinical features
Epidemiology
- •
Wide age range
- •
The majority of affected individuals are males (more than 70%) in their third to fifth decades
- •
The most common location is around the knee
- •
Mainly involves the periarticular tendons, ligaments, joint capsule, muscles, and the adjacent subcutis
Presentation
- •
Most cases present as a mass, sometimes associated with pain
Prognosis and treatment
- •
Benign tumors often cured by complete excision
- •
Recurrence is common; can be multiple
- •
Recurrence usually takes place within 18 months
- •
Recurrence commonly involves subcutaneous adipose tissue
Pathology
Histology
- •
Histologically virtually identical to intramuscular myxoma
- •
Unlike intramuscular myxoma, cystic changes are more common, and rare mitoses as well as atypical reactive cells can be seen
Immunohistochemistry/special stains
- •
Alcian blue–positive matrix
- •
Neoplastic cells express vimentin
- •
Variable expression with CD34, desmin, and smooth muscle actin
- •
S100 protein is not normally expressed
Genetic profile
- •
Recurrent point mutations involving the GNAS1 gene are not seen
Main differential diagnoses
- •
Ganglion cyst
- •
Chondrosarcoma
- •
Low-grade myxofibrosarcoma
- •
Low-grade fibromyxoid sarcoma
- •
Myxoid liposarcoma
- •
Myxoid neurothekoma
Ectopic Hamartomatous Thymoma
Definition
- •
A rare, suprasternal, heterogeneous tumor composed of an admixture of spindle cells, epithelial cells, and adipose tissue with a presumed branchial origin
- •
Despite the name, there is no definite evidence of thymic origin or thymic differentiation
- •
The designation branchial anlage mixed tumor has been proposed to describe this entity
Clinical features
Epidemiology
- •
Majority of patients are adults
- •
Striking male predominance
Presentation
- •
Slowly growing, small, lower neck mass
Prognosis and treatment
- •
Generally benign lesion
- •
Cured by complete resection
- •
No reports of metastasis
Pathology
Histology
- •
Tumors consist of three haphazardly arranged components: epithelial cell, spindle cell, and adipose tissue
- •
Spindle cell component usually predominates
- •
The epithelial component consists of either solid or cystic squamous epithelium
- •
Glandular structures are less common
- •
The spindle cells exhibit bland-looking elongated nuclei
- •
Myoid differentiation of spindle cells is sometimes seen
- •
Myoepithelial differentiation is uncommon
- •
Tumor cells are devoid of pleomorphism
- •
Mitoses are usually absent
- •
Scattered lymphocytes may be seen
Immunohistochemistry/special stains
- •
Both epithelial and spindle cells express cytokeratins, particularly high-molecular-weight forms
- •
CD34 is expressed by the spindle cells only
- •
Androgen receptor is expressed by the spindle cells
- •
Muscle actin and myoglobin can be expressed by spindle cells
- •
Desmin and S100 protein are negative
Main differential diagnoses
- •
Ectopic cervical thymoma
- •
Thymolipoma
- •
Teratoma
- •
Biphasic synovial sarcoma
- •
Malignant peripheral nerve sheath tumor with glandular differentiation
- •
Benign mixed tumor/myoepithelioma of soft tissue
Intermediate tumors
Hemosiderotic Fibrolipomatous Tumor
Definition
- •
Also known as hemosiderotic fibrohistiocytic lipomatous lesion
- •
A rare, superficial proliferation composed of spindle cells and adipocytes that almost exclusively involves the ankle
- •
An association between myxoinflammatory fibroblastic sarcoma and hemosiderotic fibrolipomatous tumor reported recently, as both lesions can share an identical translocation at t(1;10)(p22;q24)
Clinical features
Epidemiology
- •
Affected individuals are usually adults
- •
Predilection for females
Presentation
- •
Slowly growing, may be painful
- •
Size is variable
- •
History of trauma is obtained in up to 70% of cases
Prognosis and treatment
- •
Treated by local excision
- •
Local recurrence can occur
- •
No reports of metastasis
Pathology
Histology
- •
Well-circumscribed lobules of mature adipocytes admixed with areas composed of spindle cells
- •
The spindle cell areas show striking hemosiderin deposition
- •
No or mild atypia
- •
No or rare mitoses
- •
Sometimes associated with venous stasis and can be histologically virtually identical to early pleomorphic, hyalinizing angiectatic tumor (but is not pathogenically related to this tumor)
- •
Hybrid lesions with myxoinflammatory fibroblastic sarcoma can be encountered (the two tumors do appear to be pathogenically related in at least a subset of cases)
Immunohistochemistry/special stains
- •
The spindle cells express vimentin, CD34, and calponin
Genetic profile
- •
Distinctive translocation t(1;10)(p22;q24) involving the TGFBR3 and MGEA5 genes in the great majority of cases, frequently also associated with amplifications of chromosome 3p11~12, resulting in formation of ring chromosomes (also designated marker chromosomes ) with increased expression of VGLL3 and CHMP2B genes
- •
Myxoinflammatory fibroblastic sarcoma can harbor this fusion in a subset of cases
- •
TGFBR3-MGEA5 fusions are more commonly encountered in hybrid hemosiderotic fibrolipomatous tumor/myxoinflammatory fibroblastic sarcoma lesions than in classical “pure” myxoinflammatory fibroblastic sarcomas
- •
These features suggest a pathogenical relationship between at least a subset of these two tumor types
Main differential diagnoses
- •
Spindle cell lipoma
- •
Atypical lipomatous tumor
Deep (Aggressive) Angiomyxoma
Definition
- •
A mesenchymal neoplasm composed of stellate or spindle cells that commonly exhibit myoid differentiation embedded in an abundant myxedematous stroma
Clinical features
Epidemiology
- •
Affected patients are almost exclusively females 40 to 60 years of age
- •
Much less common in women older than 60 years and does not affect children
- •
Tumors are usually deeply located in pelvic, perineal, anorectal, or retroperitoneal regions
Presentation
- •
Commonly present as asymptomatic, slowly growing mass
- •
Patients may present with feeling of pressure, discomfort, or pain
- •
Size is variable but often large (>10 cm)
Prognosis and treatment
- •
Locally aggressive tumors (intermediate)
- •
Recurrence is common, which can be late, but usually not more than once
- •
No metastases have been reported
- •
Usually managed by surgical excision
- •
May respond to hormonal therapy using gonadotropin-releasing hormone agonist
Pathology
Histology
- •
Sparsely to moderately cellular neoplasms composed of bland stellate and spindled cells embedded in a loosely collagenized, myxoid matrix with scattered vessels of varied caliber
- •
Higher cellularity may be observed at perivascular and peripheral areas
- •
Some neoplastic cells show relatively abundant eosinophilic cytoplasm and exhibit fibroblastic and myofibroblastic features and appear to be hormonally influenced
- •
Well-developed myoid differentiation best evident around medium-size blood vessels and nerve trunks
- •
Mitoses are rare or absent
Immunohistochemistry/special stains
- •
Neoplastic cells focally express desmin, smooth muscle actin, muscle specific actin, vimentin, CD34, and estrogen and progesterone receptors
- •
S100 protein is negative and Ki-67 index is very low (<1%)
- •
The myxoid stroma can often be highlighted with Alcian blue or mucicarmine stains
Main differential diagnoses
- •
Superficial angiomyxoma
- •
Angiomyofibroblastoma
- •
Low-grade myxofibrosarcoma
- •
Nerve sheath myxoma
Atypical Fibroxanthoma
Definition
- •
Distinctive proliferation confined to the dermis by convention and composed of highly atypical, epithelioid histiocyte–like cells and spindled fibroblast-like cells, in variable proportions, occurring on sun-exposed and sun-damaged skin with invariably benign clinical course
- •
Diagnosis is one of exclusion and requires additional immunohistochemistry
- •
Mutations in TP53 induced by UVA exposure have been implicated in the pathogenesis
Clinical features
Epidemiology
- •
Adult patients, most commonly in the eighth decade of life (mean age 77 years)
- •
Male predominance (M:F = 9 : 1)
- •
Ultraviolet (UV) irradiation a key factor implicated in pathogenesis
Presentation
- •
Sun-exposed and sun-damaged skin
- •
Most frequently on the scalp, followed by forehead, ear, nose, and face
- •
Rapidly growing polypoid or nodular lesion, frequently ulcerated on the surface
Prognosis and treatment
- •
Complete excision usually curative
- •
Invariably benign when strict criteria applied
- •
Virtually always benign when confined to the dermis
- •
Locally aggressive behavior and even metastasis can be seen with significant subcuticular involvement (see Pleomorphic dermal sarcoma later)
Pathology
Histology
- •
Admixture of (in variable proportions)
- •
Pleomorphic, fibroblast-like spindle cells
- •
Histiocyte-like epithelioid cells
- •
Multinucleated giant cells
- •
- •
Lesional cells growing in sheets and fascicles
- •
No connection with the epidermis
- •
Numerous mitoses, including atypical ones
- •
Tumor necrosis absent
- •
Lymphovascular invasion absent
- •
Perineural invasion absent
- •
Generally well-demarcated proliferation in the dermis
- •
Focal, limited extension into superficial subcutis not uncommon and allowed by some authorities
- •
Expansile
- •
Limited lacelike
- •
- •
Surface ulceration in about 50% of cases
- •
Epidermal collarette at the periphery of the lesion in 20%, possible extension at variable length along the base of the lesion
- •
Solar elastosis, usually marked in the surrounding dermis
- •
Diagnosis of exclusion
- •
Morphological variants (represent either a focal phenomenon or predominant/exclusive component of the lesion)
- •
Spindle cell with more limited pleomorphism
- •
Proliferation of monomorphic spindle cells
- •
No pleomorphism of conventional atypical fibroxanthoma
- •
Fascicular growth of spindle cells with eosinophilic cytoplasm
- •
High mitotic activity
- •
- •
Pseudoangiomatous or “pigmented” variant with hemosiderin deposition
- •
Areas of hemorrhage, usually coupled with hemosiderin deposition
- •
Pseudovascular spaces lined by lesional cells (pleomorphic spindle cells, epithelioid cells, multinucleated giant cells)
- •
Pleomorphic lesional cells can protrude into the pseudolumina
- •
Phagocytosis of hemosiderin and erythrocytes occasionally seen
- •
- •
Keloidal
- •
Bright eosinophilic, hypocellular/acellular, collagenous, keloidlike areas
- •
Usually a focal phenomenon
- •
Keloidal areas can be separated from the epidermis by a grenz zone
- •
Occasionally in a perivascular distribution
- •
- •
Regressing
- •
Degree of fibrosis from 10% to 90% of the lesion
- •
Thickened collagen bundles with sclerosis (early)
- •
Lamellar arrangement of collagen fibers with hyalinization (late)
- •
- •
- •
Clear cell change
- •
Numerous intracytoplasmic lipid vacuoles in lysosome-rich cells
- •
Can also represent a degenerative phenomenon
- •
Staining for glycogen uniformly negative
- •
- •
Granular cell change
- •
Bright eosinophilic granular cytoplasm
- •
Likely a degenerative phenomenon related to the accumulation of intracytoplasmic lysosomes
- •
- •
Myxoid degeneration
- •
Accumulation of hyaluronic acid in the stroma
- •
Can be highlighted by periodic acid–Schiff (PAS) or Alcian blue
- •
- •
Osteoclast-like giant cells
- •
Reactive, osteoclast-like giant cells dispersed among conventional atypical fibroxanthoma
- •
True atypical osteoclast-like giant cells also described, likely developing from large, pleomorphic, multinucleated giant cells
- •
- •
Immunohistochemistry/special stains
- •
Diagnosis of exclusion: must exclude other mimics by immunohistochemistry
- •
By definition, consistently negative for low- and high-molecular-weight cytokeratins, desmin, and S100 protein
- •
Reactive S100 protein–positive dendritic cells can on occasion be numerous and should not be mistaken for lesional cells
- •
Smooth muscle actin positivity (45%), EMA positivity (24%), usually focal
- •
CD99 and CD10 frequently positive, but very nonspecific
- •
Cytoplasmic CD31 positivity in about 10%
- •
Staining is cytoplasmic and finely granular
- •
Not as prominent as in endothelial cells
- •
Lesional macrophages can also display cytoplasmic positivity
- •
- •
Granular cell variant
- •
NKIC3 positive
- •
PAS positive after diastase digestion
- •
Main differential diagnoses
- •
Squamous cell carcinoma
- •
Metaplastic carcinoma
- •
Melanoma
- •
Angiosarcoma
- •
Leiomyosarcoma
- •
Undifferentiated (dermal) pleomorphic sarcoma
Angiomatoid Fibrous Histiocytoma
Definition
- •
Uncommon variant of fibrohistiocytic tumor characterized by the presence of cystic hemorrhagic spaces
- •
Formerly known as angiomatoid malignant fibrous histiocytoma
Clinical features
Epidemiology
- •
Affected patients are children or young adults
- •
Tumors are usually located in the subcutaneous tissue of extremities or trunk
- •
Deeply situated lesions are less commonly encountered
Presentation
- •
Superficial, slow growing
- •
Size: few millimeters to 2 cm
- •
May be associated with systemic symptoms (fever, anemia, malaise, and weight loss)
Prognosis and treatment
- •
Good outcome achieved with simple surgical excision
- •
Local recurrence is reported in 10%
- •
Deep lesions elicit higher tendency for recurrence
- •
Metastasis to local lymph nodes is seen in only 1% of cases
Pathology
Histology
- •
Pseudoencapsulated, multicystic, hemorrhagic lesions
- •
Neoplastic elements are bland-looking, round or spindle cells admixed with chronic inflammatory cells
- •
Inflammatory infiltrates can organize with germinal centers simulating lymph node metastasis
- •
Tumor cells may exhibit mild to moderate pleomorphism and occasional mitoses
Immunohistochemistry/special stains
- •
Neoplastic cells commonly express CD68, CD99, muscle actin, desmin, EMA, and calponin
- •
No reactivity with factor VIII, CD34, CD31, S100 protein, or cytokeratin
Genetic profile
- •
t(12;16)(q13;p11) creating ATF1 – FUS fusion gene, t(12;22)(q13;q12) creating ATF1 – EWSR1 fusion gene, or t(2;22)(q33;q12) creating CREB1 – EWSR1 fusion gene—this latter being the most common
Ultrastructure
- •
Cells show variable features, including fibroblastic, myofibroblastic, and histiocytic differentiation
Main differential diagnoses
- •
Aneurysmal fibrous histiocytoma
- •
Angiosarcoma
Myoepithelioma of Soft Tissue
Definition
- •
An uncommon neoplasm with features virtually identical to that of myoepithelial and mixed tumors arising in salivary glands
Clinical features
Epidemiology
- •
Tumors can present at any age
- •
Generally, uncommon in elderly patients
- •
The extremities are most commonly affected
- •
The majority of lesions are subcutaneously located
Presentation
- •
Wide age range, from toddlers to elderly (median 37 years)
- •
Male dominance (M:F about 5:2)
- •
Upper extremities, lower extremities, and back most commonly involved
- •
Usually less than 3 cm (median 0.8 cm)
Prognosis and treatment
- •
Treated with local surgical excision
- •
Local recurrence is reported in up to 20% of cases
- •
Behavior challenging to predict from histological features
- •
Frankly malignant cases are described
Pathology
Histology
- •
Tumors show similar morphology to their salivary gland counterparts
- •
Fairly circumscribed, focally infiltrative, lobulated architecture
- •
Tumors are composed of nests and cords of epithelioid–spindle cells in a variably myxochondroid matrix
- •
Ductal formation may be encountered (mixed tumor/chondroid syringoma)
- •
Chondroosseous differentiation is occasionally seen
- •
Cutaneous syncytial variant
- •
Solid or sheetlike growth of uniform ovoid to spindle cells with pale pink cytoplasm and a syncytial appearance
- •
Adipocytic metaplasia is common
- •
Immunohistochemistry/special stains
- •
The majority of tumors express keratin, calponin, and S100 protein
- •
Keratin can be more focal in the syncytial variant or absent altogether
- •
EMA, glial fibrillary acid protein, and smooth muscle actin are commonly expressed
- •
Loss of INI-1 expression is reported in half of cases
- •
Desmin expression is rarely seen
Genetic profile
- •
EWSR1 rearranged in 45% of cases with a variety of partners, including
- •
EWSR1-POU5F1
- •
EWSR1-PBX1
- •
EWSR1-KLF17
- •
EWSR1-PBX3
- •
EWSR1-ATF1
- •
Syncytial variant harbors EWSR1 rearrangement likely with alternative partner(s)
- •
- •
FUS rearrangements also seen
- •
FUS-KLF17
- •
FUS-POU5F1
- •
- •
PLAG1 gene rearrangement has also been reported (particularly in cases with ductal differentiation)
- •
SMARCB1 homozygous deletions in some cases
Main differential diagnoses
- •
Extraskeletal myxoid chondrosarcoma
- •
Carcinoma
- •
Melanoma
Ossifying Fibromyxoid Tumor
Definition
- •
A rare subcutaneous tumor of uncertain line of differentiation characterized by a peripheral shell of woven bone and a lobular proliferation of bland, round cells embedded in a fibromyxoid matrix
- •
An incomplete Schwannian and/or chondroid line of differentiation has been suggested
- •
A rare malignant counterpart has been described
Clinical features
Epidemiology
- •
Trunk and proximal extremities are commonly affected
- •
Patients present in their middle age
- •
Male predilection is noted
Presentation
- •
Painless, small lesions
- •
Size: few millimeters to 3 cm
Prognosis and treatment
- •
Most cases show benign clinical behavior
- •
Atypical and frankly malignant tumors tend to recur and metastasize to lungs
Pathology
Histology
- •
Well-circumscribed lobules composed of small, round to polygonal cells embedded in a richly vascularized fibromyxoid matrix
- •
A shell of metaplastic bone is seen in two-thirds of cases
- •
Mitoses are fewer than 2 per 50 high-power fields
- •
Chondroid differentiation is a rare phenomenon
- •
Malignant cases exhibit increased cellularity, atypia, mitoses, necrosis, and invasion of vascular spaces
Immunohistochemistry/special stains
- •
Neoplastic cells express S100 protein and desmin
Genetic profile
- •
Variety of fusion transcripts reported
- •
EP400 – PHF1 (≈40 %)
- •
Less common
- •
ZC3H7B-BCOR
- •
MEAF6-PHF1
- •
EPC1-PHF1
- •
CREBBP-BCORL1
- •
KDM2A-WWTR1
- •
- •
Main differential diagnoses
- •
Extraskeletal myxoid chondrosarcoma
- •
Chondroid syringoma
- •
Melanocytic neoplasia